Browsing Tag
Citi
46 posts
Arm Performix launches as Arm Holdings (NASDAQ: ARM) extends agentic AI play beyond silicon
Arm built the silicon. Now it wants to own the optimisation layer above it. Performix is free, agent-ready, and aimed squarely at the x86 migration question.
Ligand Pharmaceuticals (LGND) to acquire XOMA Royalty (XOMA) for $739m as biotech royalty consolidation accelerates
Ligand is buying XOMA for $739 million in cash. The real story sits inside a CVR tied to a $19.7 billion Johnson and Johnson royalty fight.
How the UK fell below NATO’s defence average and what it means for BAE and peers
Britain says it is rearming. NATO's 2025 data says London is now spending less of its economy on defence than Türkiye, and the gap is structural.
DocuSign stock and IAM platform: What DOCU retail investors need to know in 2026
DocuSign reported $3.2B in fiscal 2026 revenue with IAM platform growth accelerating. Here is what investors and enterprise buyers need to know now.
OMEX surges 90% as Odyssey Marine Exploration agrees to merge with American Ocean Minerals
American Ocean Minerals and Odyssey Marine Exploration agree to $1B merger targeting deep-sea polymetallic nodules. What it means for U.S. critical minerals. Read more.
Antofagasta (LON: ANTO): The 2027 production step-change that analysts are debating right now
Antofagasta (LON: ANTO) posted record EBITDA in 2025 as two major Chilean mine expansions target completion in 2027. Here is what retail investors need to know.
Why Flex Ltd.’s $1.1bn EP2 acquisition signals rising confidence in U.S. grid modernization spending (NASDAQ: FLEX)
Find out how Flex Ltd.’s EP2 acquisition could reshape its role in grid modernization, AI power infrastructure, and long-term earnings growth.
World’s biggest oil chokepoint closed: What the Iran crisis means for energy prices globally
Iran closes the Strait of Hormuz after US-Israel strikes; Brent crude surges 14% to $83, European gas up 70% as QatarEnergy halts LNG production.
Netflix deal under fire as Paramount unveils massive $108bn offer for Warner Bros. Discovery
Paramount’s $30 per share all-cash offer for Warner Bros. Discovery could upend Netflix’s rival bid. Find out how this blockbuster deal could change Hollywood today!
Owens & Minor sells healthcare unit to Platinum Equity for $375mn, keeps 5% stake
Find out how Owens & Minor’s $375 million sale to Platinum Equity marks a strategic shift toward home-based care and stronger financial focus.